Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates

Tim R. Cressey*, Baralee Punyawudho, Sophie Le Coeur, Gonzague Jourdain, Chalermpong Saenjum, Edmund V. Capparelli, Kanokwan Jittayanun, Siriluk Phanomcheong, Anita Luvira, Thitiporn Borkird, Achara Puangsombat, Leon Aarons, Pra Ornsuda Sukrakanchana, Saik Urien, Marc Lallemant, Suraphan Sangsawang, Jullapong Achalapong, Kanchana Preedisripipat, Chaiwat Putiyanun, Vanichaya WanchaitanawongPrapap Yuthavisuthi, Chaiwat Ngampiyaskul, Prateep Kanjanavikai, Nantasak Chotivanich, Suchat Hongsiriwon, Weerapong Suwankornsakul, Phantip Sreshthatat, Annop Kanjanasing, Ratchanee Kwanchaipanich, Boonsong Rawangban, Sadhit Santadusit, Tapnarong Jarupanich, Boonyarat Warachit, Thitiporn Siriwachirachai, Pornpimon Rojanakarin, Kraisorn Vivatpatanakul, Sansanee Hanpinitsak, Phaiboon Wanasiri, Sakulrat Srirojana, Rucha Kongpanichkul, Suthunya Bunjongpak, Prapan Sabsanong, Prateung Liampongsabuddhi, Kultida Pongdetudom, Prayoon Khamja, Noppadon Akarathum, Supha Arth Phonin, Wannee Limpitikul, Jantana Jungpipun, Ratikorn Petprakorp, The PHPT-5 study team

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science